Generic Molnupiravir 200 mg

Generic Molnupiravir 200 mg

Based on UK-approved laboratory research, Molnupiravir was created to combat COVID-19 symptoms and prevent progression to severe illness, an effort to curb the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).


Molnuvid, Molnunat, Molnatris, Movfor

Generic Molnupiravir 200 mg 40 pills/bottle

1 bottles x 40 pills/bottle $200.00
2 bottles x 40 pills/bottle $350.00
3 bottles x 40 pills/bottle $450.00
4 bottles x 40 pills/bottle $500.00
5 bottles x 40 pills/bottle $500.00


Molnupiravir has proven to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA, earning a favorable safety profile.

Therapeutic Indication: Molnupiravir is indicated for treatment of adult patients with COVID-19, with SpO2 > 93% and who have high risk of progression of the disease including hospitalization or death.